Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-18T23:12:21.312Z Has data issue: false hasContentIssue false
  • English
  • Français

Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?

Published online by Cambridge University Press:  17 July 2009

A. D. L. Roberts ,
M.-L. Charler ,
A. Papadopoulos ,
S. Wessely ,
T. Chalder  and
A. J. Cleare
A. D. L. Roberts
Affiliation:
King's College London, Institute of Psychiatry, Department of Psychological Medicine, London, UK Chronic Fatigue Syndrome Research and Treatment Unit, Maudsley Hospital, London, UK
M.-L. Charler
Affiliation:
Chronic Fatigue Syndrome Research and Treatment Unit, Maudsley Hospital, London, UK
A. Papadopoulos
Affiliation:
National Affective Disorders Unit, Maudsley and Bethlem Royal Hospitals, London, UK
S. Wessely
Affiliation:
King's College London, Institute of Psychiatry, Department of Psychological Medicine, London, UK Chronic Fatigue Syndrome Research and Treatment Unit, Maudsley Hospital, London, UK National Affective Disorders Unit, Maudsley and Bethlem Royal Hospitals, London, UK
T. Chalder
Affiliation:
King's College London, Institute of Psychiatry, Department of Psychological Medicine, London, UK Chronic Fatigue Syndrome Research and Treatment Unit, Maudsley Hospital, London, UK
A. J. Cleare*
Affiliation:
King's College London, Institute of Psychiatry, Department of Psychological Medicine, London, UK Chronic Fatigue Syndrome Research and Treatment Unit, Maudsley Hospital, London, UK National Affective Disorders Unit, Maudsley and Bethlem Royal Hospitals, London, UK
*
*Address for correspondence: Dr A. J. Cleare, Department of Psychological Medicine, Section of Neurobiology of Mood Disorders, Institute of Psychiatry, 103 Denmark Hill, LondonSE5 8AF, UK. (Email: a.cleare@iop.kcl.ac.uk)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

There is evidence that patients with chronic fatigue syndrome (CFS) have mild hypocortisolism. The clinical significance of this is unclear. We aimed to determine whether hypocortisolism exerted any effect on the response of CFS to cognitive behavioural therapy (CBT).

Method

We measured 24-h urinary free cortisol (UFC) in 84 patients with Centers for Disease Control and Prevention (CDC)-defined CFS (of whom 64 were free from psychotropic medication) who then received CBT in a specialist, tertiary out-patient clinic as part of their usual clinical care. We also measured salivary cortisol output from 0800 to 2000 h in a subsample of 56 psychotropic medication-free patients.

Results

Overall, 39% of patients responded to CBT after 6 months of treatment. Lower 24-h UFC output was associated with a poorer response to CBT but only in psychotropic medication-free patients. A flattened diurnal profile of salivary cortisol was also associated with a poor response to CBT.

Conclusions

Low cortisol is of clinical relevance in CFS, as it is associated with a poorer response to CBT. Hypocortisolism could be one of several maintaining factors that interact in the persistence of CFS.

Keywords

Chronic fatigue syndromecognitive behavioural therapycortisolHPA axismyalgic encephalomyelitis
Type
Original Articles
Information
Psychological Medicine , Volume 40 , Issue 3 , March 2010 , pp. 515 - 522
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. American Psychiatric Association: Washington, DC.Google Scholar
Beck, AT, Ward, C, Mendelson, M (1961). Beck Depression Inventory (BDI). Archives of General Psychiatry 4, 561–571.CrossRefGoogle Scholar
Butler, S, Chalder, T, Ron, M, Wessely, S (1991). Cognitive behaviour therapy in chronic fatigue syndrome. Journal of Neurology, Neurosurgery and Psychiatry 54, 153–158.CrossRefGoogle ScholarPubMed
Buysse, DJ, Reynolds, CF 3rd, Monk, TH, Berman, SR, Kupfer, DJ (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research 28, 193–213.CrossRefGoogle ScholarPubMed
Cevik, R, Gur, A, Acar, S, Nas, K, Sarac, AJ (2004). Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones. BMC Musculoskeletal Disorders 5, 47.CrossRefGoogle ScholarPubMed
Chalder, T, Berelowitz, G, Hirsch, S, Pawlikowska, T, Wallace, P, Wessely, S, Wright, D (1993). Development of a fatigue scale. Journal of Psychosomatic Research 37, 147–153.CrossRefGoogle ScholarPubMed
Cleare, AJ (2003). The neuroendocrinology of chronic fatigue syndrome. Endocrine Reviews 24, 236–252.CrossRefGoogle ScholarPubMed
Cleare, AJ (2004). The HPA axis and the genesis of chronic fatigue syndrome. Trends in Endocrinology and Metabolism 15, 55–59.CrossRefGoogle ScholarPubMed
Cleare, AJ, Blair, D, Chambers, S, Wessely, S (2001 a). Urinary free cortisol in chronic fatigue syndrome. American Journal of Psychiatry 158, 641–643.CrossRefGoogle ScholarPubMed
Cleare, AJ, Heap, E, Malhi, GS, Wessely, S, O'Keane, V, Miell, J (1999). Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 353, 455–458.CrossRefGoogle ScholarPubMed
Cleare, AJ, Miell, J, Heap, E, Sookdeo, S, Young, L, Malhi, GS, O'Keane, V (2001 b). Hypothalamo-pituitary-adrenal axis function in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Journal of Clinical Endocrinology and Metabolism 86, 3545–3554.CrossRefGoogle ScholarPubMed
Deale, A, Chalder, T, Marks, I, Wessely, S (1997). A randomized controlled trial of cognitive behaviour versus relaxation therapy for chronic fatigue syndrome. American Journal of Psychiatry 154, 408–414.Google Scholar
Deale, A, Chalder, T, Wessely, S (2000). Illness beliefs and treatment outcome in chronic fatigue syndrome. Journal of Psychosomatic Research 45, 77–83.CrossRefGoogle Scholar
Fukuda, K, Straus, S, Hickie, I, Sharpe, M, Dobbins, J, Komaroff, A (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 121, 953–959.CrossRefGoogle ScholarPubMed
Goldberg, DP, Blackwell, B (1970). Psychiatric illness in general practice: a detailed study using a new method of case identification. British Medical Journal 2, 439–443.CrossRefGoogle Scholar
Guy, W (1976). ECDEU Assessment Manual for Psychopharmacology, Revised. US Government Printing Office: Washington, DC.Google Scholar
Heim, C, Nater, UM, Maloney, E, Boneva, R, Jones, JF, Reeves, WC (2009). Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Archives of General Psychiatry 66, 72–80.CrossRefGoogle ScholarPubMed
Jerjes, WK, Cleare, AJ, Wessely, S, Wood, PJ, Taylor, NF (2005). Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. Journal of Affective Disorders 87, 299–304.CrossRefGoogle ScholarPubMed
Jerjes, WK, Peters, TJ, Taylor, NF, Wood, PJ, Wessely, S, Cleare, AJ (2006). Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. Journal of Psychosomatic Research 60, 145–153.CrossRefGoogle ScholarPubMed
McKenzie, R, O'Fallon, A, Dale, J, Demitrack, M, Sharma, G, Deloria, M, Garica-Borreguero, D, Blackwelder, W, Straus, S (1998). Low-dose hydrocortisone treatment of chronic fatigue syndrome: results of a placebo-controlled study of its efficacy and safety. Journal of the American Medical Association 280, 1061–1066.CrossRefGoogle Scholar
Mundt, JC, Marks, IM, Shear, K, Griest, JH (2002). The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry 180, 461–464.CrossRefGoogle Scholar
Nater, UM, Youngblood, LS, Jones, JF, Unger, ER, Miller, AH, Reeves, WC, Heim, C (2008). Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosomatic Medicine 70, 298–305.CrossRefGoogle Scholar
Pariante, CM, Papadopoulos, AS, Poon, L, Checkley, SA, English, J, Kerwin, RW, Lightman, S (2002). A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis. Biological Psychiatry 51, 922–930.CrossRefGoogle ScholarPubMed
Prins, J, Bleijenberg, G, Bazelmans, E, Elving, L, de Boo, T, Severens, H, van der Wilt, G, Spinhoven, P, van der Meer, J (2001). Cognitive behaviour therapy for chronic fatigue syndrome: a multicenter randomised controlled trial. Lancet 357, 841–847.CrossRefGoogle ScholarPubMed
Quarmby, L, Rimes, KA, Deale, A, Wessely, S, Chalder, T (2007). Cognitive-behaviour therapy for chronic fatigue syndrome: comparison of outcomes within and outside the confines of a randomised controlled trial. Behaviour Research and Therapy 45, 1085–1094.CrossRefGoogle ScholarPubMed
Reid, S, Chalder, T, Cleare, A, Hotopf, M, Wessely, S (2005). Chronic fatigue syndrome. Clinical Evidence 14, 1366–1378.Google Scholar
Roberts, ADL, Wessely, S, Chalder, T, Papadopoulos, A, Cleare, AJ (2004). Salivary cortisol response to awakening in chronic fatigue syndrome. British Journal of Psychiatry 184, 136–141.CrossRefGoogle ScholarPubMed
Sharpe, M, Archard, L, Banatvala, J, Borysiewicz, L, Clare, A, David, A, Edwards, R, Hawton, K, Lambert, H, Lane, R, McDonald, E, Mowbray, J, Pearson, D, Peto, T, Preedy, V, Smith, A, Smith, D, Taylor, D, Tyrrell, D, Wessely, S, White, P (1991). Chronic fatigue syndrome: guidelines for research. Journal of the Royal Society of Medicine 84, 118–121.CrossRefGoogle ScholarPubMed
Sharpe, M, Chalder, T, Palmer, I, Wessely, S (1997). Chronic fatigue syndrom. A practical guide to assessment and management. General Hospital Psychiatry 19, 185–199.CrossRefGoogle ScholarPubMed
Thase, ME, Dube, S, Bowler, K, Howland, RH, Myers, JE, Friedman, E, Jarrett, DB (1996). Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients. American Journal of Psychiatry 153, 886–891.Google ScholarPubMed
Ware, JE, Sherbourne, CD (1992). The MOS 36-item short form health survey (SF-36). Medical Care 30, 473–483.CrossRefGoogle ScholarPubMed
Wessely, S, Hotopf, M, Sharpe, M (1998). Chronic Fatigue and its Syndromes. Oxford University Press: Oxford.CrossRefGoogle Scholar
Whiting, P, Bagnall, AM, Sowden, AJ, Cornell, JE, Mulrow, CD, Ramirez, G (2001). Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. Journal of the American Medical Association 286, 1360–1368.CrossRefGoogle ScholarPubMed
WHO (1994). Schedules for Clinical Assessment in Neuropsychiatry, Version 2.0. Manual. World Health Organization: Geneva.Google Scholar
Wolfe, F, Smythe, H, Yunus, M, Bennett, R, Bombardier, C, Goldenberg, D, Tugwell, P, Campbell, S, Abeles, M, Clark, P, Fam, A, Farber, S, Feichtner, J, Franklin, C, Gatter, R, Hamaty, D, Lessard, J, Lichtbroun, A, Masi, A, McGain, G, Reynolds, W, Romano, T, Russell, I, Sheon, R (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis and Rheumatism 33, 160–173.CrossRefGoogle ScholarPubMed